the challenge of treating bpdcn in a resource-limited setting
Published 2 months ago • 42 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
3:59
the challenges of treating bpdcn and the role of diagnostic markers
-
0:56
challenges associated with treating bpdcn: the rarity of the disease
-
1:13
the challenges of treating patients with mpns who possess a tp53 mutation
-
1:44
long-term results from a trial of tag in patients with bpdcn
-
0:57
bpdcn: unmet needs and challenges
-
4:25
the challenges with accurately diagnosing and risk-stratifying patients with mds
-
1:23
the challenge of relapse in transplant-eligible & transplant-ineligible patients with bdpcn
-
1:04
the challenge of treating hma-refractory mds patients
-
26:46
the complete blood count (cbc) test / the full blood count (fbc) test
-
13:54
dksh scientific: เสียงตอบรับจากผู้ใช้งานจริง จาก บริษัท icp international co., ltd.
-
7:23
compactdry®
-
0:59
advancing the understanding of bpdcn through international collaboration
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
1:44
remodl-b: bortezomib r-chop versus r-chop in patients with dlbcl
-
1:14
the challenges associated with treating patients with non-transfusion-dependent thalassemia
-
1:16
predictors of long-term survival in patients with dlbcl/hgbcl following autosct
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all
-
2:56
mrd testing in the clinical setting: challenges in practice
-
2:12
the current challenges and unmet needs in myelofibrosis: clinical practice and trials
-
4:15
phase ib/ii trial of quizartinib, decitabine and venetoclax in flt3-itd-mutated aml
-
21:06
introduction to batched products
-
3:10
the potential for early identification of relapse in dlbcl using serial ctdna sampling